Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ports MO"'
Autor:
Qin JS; Juno Therapeutics, a Celgene Company, Seattle, WA., Johnstone TG; Juno Therapeutics, a Celgene Company, Seattle, WA., Baturevych A; Juno Therapeutics, a Celgene Company, Seattle, WA., Hause RJ; Juno Therapeutics, a Celgene Company, Seattle, WA., Ragan SP; Juno Therapeutics, a Celgene Company, Seattle, WA., Clouser CR; Juno Therapeutics, a Celgene Company, Seattle, WA., Jones JC; Juno Therapeutics, a Celgene Company, Seattle, WA., Ponce R; Juno Therapeutics, a Celgene Company, Seattle, WA., Krejsa CM; Acerta Pharma, a member of the AstraZeneca Group, South San Francisco, CA., Salmon RA; Juno Therapeutics, a Celgene Company, Seattle, WA., Ports MO; Juno Therapeutics, a Celgene Company, Seattle, WA.
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2020 May; Vol. 43 (4), pp. 107-120.
Autor:
Works M; Juno Therapeutics, A Celgene Company, Seattle, Washington. Melissa.works@junotherapeutics.com., Soni N; Juno Therapeutics, A Celgene Company, Seattle, Washington., Hauskins C; Juno Therapeutics, A Celgene Company, Seattle, Washington., Sierra C; Juno Therapeutics, A Celgene Company, Seattle, Washington., Baturevych A; Juno Therapeutics, A Celgene Company, Seattle, Washington., Jones JC; Juno Therapeutics, A Celgene Company, Seattle, Washington., Curtis W; Juno Therapeutics, A Celgene Company, Seattle, Washington., Carlson P; Juno Therapeutics, A Celgene Company, Seattle, Washington., Johnstone TG; Juno Therapeutics, A Celgene Company, Seattle, Washington., Kugler D; Juno Therapeutics, A Celgene Company, Seattle, Washington., Hause RJ; Juno Therapeutics, A Celgene Company, Seattle, Washington., Jiang Y; Juno Therapeutics, A Celgene Company, Seattle, Washington., Wimberly L; Juno Therapeutics, A Celgene Company, Seattle, Washington., Clouser CR; Juno Therapeutics, A Celgene Company, Seattle, Washington., Jessup HK; Juno Therapeutics, A Celgene Company, Seattle, Washington., Sather B; Juno Therapeutics, A Celgene Company, Seattle, Washington., Salmon RA; Juno Therapeutics, A Celgene Company, Seattle, Washington., Ports MO; Juno Therapeutics, A Celgene Company, Seattle, Washington.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2019 Dec; Vol. 18 (12), pp. 2246-2257. Date of Electronic Publication: 2019 Aug 08.
Autor:
Farand J; Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, California 94404, United States., Kropf JE; Gilead Sciences, Inc. 199 East Blaine Street, Seattle, Washington 98102, United States., Blomgren P; Gilead Sciences, Inc. 199 East Blaine Street, Seattle, Washington 98102, United States., Xu J; Gilead Sciences, Inc. 199 East Blaine Street, Seattle, Washington 98102, United States., Schmitt AC; Gilead Sciences, Inc. 199 East Blaine Street, Seattle, Washington 98102, United States., Newby ZE; Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, California 94404, United States., Wang T; Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, California 94404, United States., Murakami E; Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, California 94404, United States., Barauskas O; Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, California 94404, United States., Sudhamsu J; Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, California 94404, United States., Feng JY; Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, California 94404, United States., Niedziela-Majka A; Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, California 94404, United States., Schultz BE; Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, California 94404, United States., Schwartz K; Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, California 94404, United States., Viatchenko-Karpinski S; Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, California 94404, United States., Kornyeyev D; Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, California 94404, United States., Kashishian A; Gilead Sciences, Inc. 199 East Blaine Street, Seattle, Washington 98102, United States., Fan P; Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, California 94404, United States., Chen X; Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, California 94404, United States., Lansdon EB; Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, California 94404, United States., Ports MO; Gilead Sciences, Inc. 199 East Blaine Street, Seattle, Washington 98102, United States., Currie KS; Gilead Sciences, Inc. 199 East Blaine Street, Seattle, Washington 98102, United States., Watkins WJ; Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, California 94404, United States., Notte GT; Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, California 94404, United States.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2019 Nov 19; Vol. 11 (3), pp. 358-364. Date of Electronic Publication: 2019 Nov 19 (Print Publication: 2020).
Autor:
Aeffner F; Flagship Biosciences Inc., Westminster, CO, USA., Martin NT; Flagship Biosciences Inc., Westminster, CO, USA., Peljto M; Flagship Biosciences Inc., Westminster, CO, USA., Black JC; Flagship Biosciences Inc., Westminster, CO, USA., Major JK; Flagship Biosciences Inc., Westminster, CO, USA., Jangani M; Centre for Cancer and Inflammation, Barts Cancer Institute, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK., Ports MO; Gilead Sciences, Seattle, WA, USA., Krueger JS; Flagship Biosciences Inc., Westminster, CO, USA., Young GD; Flagship Biosciences Inc., Westminster, CO, USA.
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology [Lab Invest] 2016 Dec; Vol. 96 (12), pp. 1327-1336. Date of Electronic Publication: 2016 Oct 24.